Home » Topics » BioWorld Science

BioWorld Science
RSS

T cell receptor vaccine effective in MS

April 12, 1996

ABT-089 candidate drug for Alzheimer's disease

April 12, 1996

Neruocrine Biosciences, Ciba-Geigy ally for MS research

April 12, 1996

Carbonic anhydrase inhibitor tested for parkinsonism

April 12, 1996

Genentech to develop neurturin for neurodegenerative disorders

April 12, 1996

Paracelsian option to acquire East West Herbs

April 12, 1996

Isopharma established to develop radioactive healthcare products

April 12, 1996

Fujisawa acquires equity interest in PharMingen

April 12, 1996

Pharmacopeia will collaborate with Daiichi for drug discovery

April 12, 1996

RMP-7 phase II trials initiated

April 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 7, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 7, 2024.
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...
Sanofi bets on Resalis’ oligonucleotide RES-010 for obesity
BioWorld
After missing out on the glucagon-like peptide 1 obesity market, Sanofi SA is prospecting for next-generation drugs and is making a strategic equity investment in...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.